Invention Grant
US09023812B2 Neuroprotective ganglioside compositions for use in treating huntington's disease
有权
用于治疗亨廷顿氏病的神经保护神经节苷脂组合物
- Patent Title: Neuroprotective ganglioside compositions for use in treating huntington's disease
- Patent Title (中): 用于治疗亨廷顿氏病的神经保护神经节苷脂组合物
-
Application No.: US13394106Application Date: 2010-08-20
-
Publication No.: US09023812B2Publication Date: 2015-05-05
- Inventor: Simonetta Sipione , Vittorio Maglione
- Applicant: Simonetta Sipione , Vittorio Maglione
- Applicant Address: CA Edmonton
- Assignee: The Governors of the University of Alberta
- Current Assignee: The Governors of the University of Alberta
- Current Assignee Address: CA Edmonton
- International Application: PCT/CA2010/001282 WO 20100820
- International Announcement: WO2011/026216 WO 20110310
- Main IPC: A61K31/7032
- IPC: A61K31/7032 ; G01N33/68 ; A61K9/00
Abstract:
Huntington's disease (HD) is a neurodegenerative disorder caused by the expansion of a polyglutamine stretch in the protein huntingtin (Htt). HD neurons are dysfunctional at multiple levels and have increased susceptibility to stress and apoptotic stimuli. As described therein there is provided compound(s), composition(s), methods and/or kits for the treatment and/or diagnosis of Huntington's disease.
Public/Granted literature
- US20120283199A1 NEUROPROTECTIVE GANGLIOSIDE COMPOSITIONS FOR USE IN TREATING OR DIAGNOSING HUNTINGTON'S DISEASE Public/Granted day:2012-11-08
Information query
IPC分类:
